(Q44071226)

29 November 2017

0 references

Lipoprotein-associated phospholipase A2 gene V279F polymorphisms and coronary heart disease: a meta-analysis (English)

1 reference

29 November 2017

1 reference

coronary artery disease

1 reference

Guo-Hua Zheng

1

1 reference

29 November 2017

Hai-Ying Chen

series ordinal

2

1 reference

29 November 2017

Shang-Quan Xiong

series ordinal

3

1 reference

29 November 2017

Jian-Feng Chu

series ordinal

4

1 reference

29 November 2017

24 November 2010

1 reference

Molecular Biology Reports

29 November 2017

1 reference

29 November 2017

38

1 reference

29 November 2017

6

1 reference

29 November 2017

4089-4099

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-010-0529-9

29 November 2017

0 references

cites work

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

A method for meta-analysis of molecular association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Problems of reporting genetic associations with complex outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

The Val279Phe Variant of the Lipoprotein-Associated Phospholipase A2 Gene Is Associated with Catalytic Activities and Cardiovascular Disease in Korean Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0529-9

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

12 December 2020

Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study

1 reference

12 December 2020

High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients

1 reference

12 December 2020

Association of platelet-activating factor acetylhydrolase gene polymorphism with premature coronary artery disease in Turkish patients

1 reference

12 December 2020

Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis

1 reference

12 December 2020

Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease

1 reference

12 December 2020

Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction

1 reference

12 December 2020

Oxidized phospholipids as a new landmark in atherosclerosis

1 reference

12 December 2020

Inflammatory markers of coronary risk

1 reference

12 December 2020

Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population

1 reference

12 December 2020

Association of a G994-->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese

1 reference

12 December 2020

10.1007/S11033-010-0529-9

Identifiers

DOI

1 reference

29 November 2017

1 reference